CF
Cantor Fitzgerald Latest Price Targets & Analyst Ratings
| Stock | Analyst | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|---|
526
Fate Therapeutics
FATE
$111M
|
AY
Alethia Young
| $0.9799 | $98 |
9,901%
upside
| Overweight |
25 Feb ‘21
4 years ago |
|
527
Amgen
AMGN
$151B
|
AY
Alethia Young
| $279.97 | $295 |
5%
upside
| Overweight |
3 Feb ‘21
4 years ago |
|
528
Evogene
EVGN
$10.8M
|
KK
Kristen Kluska
| $1.24 | $90 |
7,158%
upside
| Overweight |
1 Dec ‘20
4 years ago |
|
529
Root
ROOT
$1.52B
|
SH
Steven Halper
| $98.33 | $504 |
413%
upside
| Overweight |
23 Nov ‘20
4 years ago |
|
530
Gilead Sciences
GILD
$144B
|
AY
Alethia Young
| $115.76 | $86 |
26%
downside
| Overweight |
29 Oct ‘20
4 years ago |
|
531
TG Therapeutics
TGTX
$5.08B
|
AY
Alethia Young
| $32 | $48 |
50%
upside
| Overweight |
28 Oct ‘20
4 years ago |
|
532
Cassava Sciences
SAVA
$105M
|
CD
Charles Duncan
| $2.18 | $24 |
1,001%
upside
| Overweight |
23 Oct ‘20
4 years ago |
|
533
Gossamer Bio
GOSS
$630M
| $2.77 | $20 |
622%
upside
| Overweight |
14 Oct ‘20
4 years ago |
|
|
|
BCYC
534
Bicycle Therapeutics
BCYC
$485M
|
AY
Alethia Young
| $7.12 | $30 |
321%
upside
| Overweight |
12 Oct ‘20
4 years ago |
|
535
Zentalis Pharmaceuticals
ZNTL
$118M
|
EM
Eliana Merle
| $1.60 | $44 |
2,650%
upside
| Overweight |
29 Sep ‘20
5 years ago |
|
536
Inovio Pharmaceuticals
INO
$146M
|
CD
Charles Duncan
| $2.75 | $144 |
5,136%
upside
| Neutral |
28 Sep ‘20
5 years ago |
|
537
Galapagos
GLPG
$2.21B
|
EM
Eliana Merle
| $32.67 | $134 |
310%
upside
| Neutral |
19 Aug ‘20
5 years ago |
|
538
GoHealth
GOCO
$75.8M
|
SH
Steven Halper
| $4.79 | $390 |
8,042%
upside
| Overweight |
10 Aug ‘20
5 years ago |
|
539
Neurocrine Biosciences
NBIX
$14.3B
| $144.17 | $161 |
12%
upside
| Overweight |
4 Aug ‘20
5 years ago |
|
|
540
Agios Pharmaceuticals
AGIO
$2.1B
|
AY
Alethia Young
| $36.15 | $72 |
99%
upside
| Overweight |
31 Jul ‘20
5 years ago |
|
541
Emergent Biosolutions
EBS
$441M
|
BF
Brandon Folkes
| $8.26 | $110 |
1,232%
upside
| Overweight |
17 Jul ‘20
5 years ago |
|
542
Vaxcyte
PCVX
$4.21B
| $32.72 | $55 |
68%
upside
| Overweight |
7 Jul ‘20
5 years ago |
|
|
543
SelectQuote
SLQT
$351M
| $2.03 | $32 |
1,476%
upside
| Overweight |
15 Jun ‘20
5 years ago |
|
|
544
Zoom
ZM
$25.6B
|
DK
Drew Kootman
| $85.62 | $261 |
205%
upside
| Overweight |
3 Jun ‘20
5 years ago |
|
545
Pacific Biosciences
PACB
$393M
|
AY
Alethia Young
| $1.31 | $5 |
282%
upside
| Overweight |
2 Jun ‘20
5 years ago |
|
546
Exagen
XGN
$216M
| $9.80 | $20 |
104%
upside
| Overweight |
2 Jun ‘20
5 years ago |
|
|
547
Evolent Health
EVH
$1.16B
|
SH
Steven Halper
| $9.99 | $8 |
20%
downside
| Neutral |
2 Jun ‘20
5 years ago |
|
548
Geron
GERN
$868M
|
CD
Charles Duncan
| $1.36 | $4 |
194%
upside
| Overweight |
1 Jun ‘20
5 years ago |
|
549
Puma Biotechnology
PBYI
$230M
| $4.71 | $16 |
240%
upside
| Neutral |
20 May ‘20
5 years ago |
|
|
550
Incyte
INCY
$16.9B
|
AY
Alethia Young
| $85.60 | $100 |
17%
upside
| Neutral |
19 May ‘20
5 years ago |
|